Sale is live|00:00:00

Expleo Solutions Ltd Q1 FY27 Earnings Analysis

Published 14 Jun 2026 | IT - Services | Market Cap: ₹1.4K Cr

Price

785

Market Cap

₹1.4K Cr

P/E Ratio

10.2

Revenue Rank

Rank 3

Margin Rank

Rank 3

Earnings Summary

- Expectation of sustainable double-digit revenue growth in FY '27 despite uncertainties. - FY ’26 reported 8.1% revenue growth to INR 11,080 million; however, constant currency revenue slightly declined by 0.4%.

📊 Revenue & Sales Performance

Rank 3

- Expectation of sustainable double-digit revenue growth in FY '27 despite uncertainties. - Growth driven by four key levers: new logo acquisition, growing existing accounts, sector focus (payments and aerospace defense), and people investments. - Strong pipeline validated by increased demand, exemplified by new facility for aerospace defense test bench manufacturing. - Revenue from aerospace and defense expected to grow due to Make in India initiatives and geopolitical factors, though timing of manufacturing monetization remains uncertain. - Expansion into new geographies like Egypt, leveraging Middle East success, to fuel new business growth. - Increased adoption of AI expected to influence 60% of revenue by expanding scope with existing clients, though it pressures ticket sizes. - Revenue from Expleo Group remains stable around 30%-33%, showing growth from group business contributing positively. - Focus on growing payments sector within BFSI to capture regulatory-driven investments.

📈 Profitability & Margins

Rank 3

- FY ’26 reported 8.1% revenue growth to INR 11,080 million; however, constant currency revenue slightly declined by 0.4%. - Adjusted EBITDA margin for FY ’26 decreased slightly to 15.6% from 16.2% in FY ’25 due to wage increments and labor code impacts. - Profit after tax margin improved to 12.3% from 9.8% primarily from higher other income (forex gains). - EPS increased significantly by 20.1% to INR 79.89 in FY ’26. - For FY ’27, company targets sustainable double-digit revenue growth with stable EBITDA margins around 15-16%. - Growth drivers include expansion in aerospace & defense (Make in India), financial services with AI integration, Middle East and new geographies (e.g., Egypt). - Management expects continued revenue gains from AI-related productivity, albeit passing majority of these productivity benefits to customers. - Uncertainties around geopolitical issues and government contracts may affect aerospace growth timing.

🏗️ Capital Expenditure Plans

Yes

- Expleo Solutions Limited inaugurated a new, larger facility in Bangalore to support increasing aerospace and defense demand, particularly for test bench production. - The new facility includes a lab to meet higher test bench production requirements. - There is a focus on investments in the payments sector, including the development of simulators compatible with Mastercard, Visa, RuPay, American Express, and UPIs, anticipating regulatory deadlines in 2028. - The company is pursuing an aggressive partner-led growth strategy with over 15 partners for joint go-to-market activities globally, indicating possible strategic investments in partnerships. - Expleo is actively pursuing mergers and acquisitions (M&A), having identified nine potential targets with three in due diligence, aiming at U.S.-based companies offering complementary AI, data, and implementation services to deepen U.S. market presence. - Continued investment in people through the AI 360 training program to upskill employees on AI technologies.

💰 Fundraising & Capital Structure

Yes

- The company is prioritizing execution of its M&A strategy, having identified and screened targets already, with a timeline indicated for completion (Page 13). - No explicit mention of new fundraising through debt or equity in the provided excerpts. - Loans of INR 100 crores have been given to related parties within the Group at an arm's length interest rate of around 9.5% to 10%, but this is not a fundraising activity (Page 12). - Dividend payment is deprioritized to focus on M&A execution (Page 13). - Overall, there is no direct disclosure of plans for new debt or equity fundraising in the current/future period within these pages.

📋 Order Book & Pipeline

No information

- The transcript does not explicitly provide specific details on the current or expected order book or pending orders for Expleo Solutions Limited. - However, it indicates a strong pipeline validated by acquisition of a larger lab and a new state-of-the-art facility in Bangalore, primarily driven by increasing demand in aerospace and defense sectors. - There is strong demand from aerospace defense, especially due to "Make in India" initiatives and manufacturing activities for aircraft like Rafale, Boeing, Airbus, and Dassault Aviation, though actual manufacturing timelines have been delayed. - AI-infused services are expanding in BFSI and technology sectors, driving continuous business growth and renewals. - The company anticipates continued growth supported by increasing AI adoption (15% of revenues are AI-influenced) and expanding footprints in aerospace, defense, and BFSI. - Overall, while uncertainties remain, the outlook points toward a healthy demand pipeline fueling growth prospects.

Key Metrics

Revenue

Rank 3

Margin

Rank 3

Capex

Yes

Fundraise

Yes

Order Book

No information

Frequently Asked Questions

What were Expleo Solutions Ltd Q1 FY27 results?

- Expectation of sustainable double-digit revenue growth in FY '27 despite uncertainties. - FY ’26 reported 8.1% revenue growth to INR 11,080 million; however, constant currency revenue slightly declined by 0.4%.

What is Expleo Solutions Ltd share price analysis?

Expleo Solutions Ltd currently shows a below-average growth signal. The stock trades at a P/E of 10.2 with a market cap of ₹1,375. Investors should review the full earnings analysis for detailed insights.

Is Expleo Solutions Ltd planning capital expenditure?

- Expleo Solutions Limited inaugurated a new, larger facility in Bangalore to support increasing aerospace and defense demand, particularly for test bench production.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.